November 03, 2025

Metastatic ER-Positive, HER2-Negative Breast Cancer: Novel Treatment Combination Improves Progression-Free Survival

Patients with ER-positive, HER2-negative advanced breast cancer showed significantly improved progression-free survival (PFS) when treated with an oral combination regimen that includes giredestrant, ...

The ASCO Post

October 31, 2025

A Young Hematologist’s Take on ICML 2025

The ASCO Post

October 31, 2025

Addition of Brentuximab Vedotin to Lenalidomide/Rituximab in Relapsed or Refractory DLBCL

The ASCO Post

November 06, 2025

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

The ASCO Post

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

The ASCO Post

October 30, 2025

Digital Histopathology and Automated Classification of Pediatric Sarcomas

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

November 10, 2025

Improving the Appropriate Prescribing of Olanzapine for Chemotherapy-Induced Nausea and Vomiting: A Quality Improvement Initiative for the Outpatient Oncology Practice

JADPRO

November 10, 2025

Enhancing Adverse Event Identification and Management in Early-Phase Oncology Clinical Trials: The Emerging Role of Advanced Practice Providers

JADPRO

November 10, 2025

Long-Term Safety and Management of Adverse Events Associated With Lorlatinib in ALK-Positive Metastatic NSCLC: A Fictional Case Study

JADPRO

November 10, 2025

Creatine

The ASCO Post

November 10, 2025

Cutaneous T-Cell Lymphoma: Use of Durvalumab Alone or With Lenalidomide Under Study in Phase II Trial

The ASCO Post

November 10, 2025

Alcohol and Cancer Risk: Is a Drop Too Much?

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

SOHO 2025

November 10, 2025

Cutaneous T-Cell Lymphoma: Use of Durvalumab Alone or With Lenalidomide Under Study in Phase II Trial

The ASCO Post

October 08, 2025

Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia

The ASCO Post

October 08, 2025

Early Study Results With Novel Bruton’s Tyrosine Kinase Degrader in Relapsed or Refractory Chronic Lymphocytic Leukemia

The ASCO Post

ESMO Congress 2025

November 10, 2025

HER2-Positive Early Breast Cancer: Trastuzumab Deruxtecan Moves Into Earlier Clinical Settings

The ASCO Post

November 10, 2025

Perioperative Immunotherapy Regimen Improves Outcomes in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

The ASCO Post

November 05, 2025

RCC: Lenvatinib/Everolimus Extends PFS After PD-1 Inhibition

The ASCO Post

ACG 2025 Annual Scientific Meeting

November 10, 2025

Gastric microbiome shifts track H pylori virulence

Conexiant

November 05, 2025

Bariatric surgery vs GLP-1s: GERD risk

Conexiant

Clinical Guidelines

November 10, 2025

Improving the Appropriate Prescribing of Olanzapine for Chemotherapy-Induced Nausea and Vomiting: A Quality Improvement Initiative for the Outpatient Oncology Practice

JADPRO

November 10, 2025

Enhancing Adverse Event Identification and Management in Early-Phase Oncology Clinical Trials: The Emerging Role of Advanced Practice Providers

JADPRO

November 10, 2025

Long-Term Safety and Management of Adverse Events Associated With Lorlatinib in ALK-Positive Metastatic NSCLC: A Fictional Case Study

JADPRO

November 10, 2025

HER2-Positive Early Breast Cancer: Trastuzumab Deruxtecan Moves Into Earlier Clinical Settings

The ASCO Post

Commentary & Perspectives

November 10, 2025

Creatine

The ASCO Post

November 10, 2025

Alcohol and Cancer Risk: Is a Drop Too Much?

The ASCO Post

November 06, 2025

How Embedding an Algorithm-Based Referral System Into Electronic Health Records Is Increasing Access to Palliative Care

The ASCO Post

November 06, 2025

Physician-Complementing Artificial Intelligence in Oncology

The ASCO Post

FDA & Government News

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

February 21, 2024

FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma

The ASCO Post

June 21, 2023

FDA Launches Pilot Program to Help Reduce Risks Associated With Using Laboratory Developed Tests to Identify Cancer Biomarkers

The ASCO Post

Business Management

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

Digital Histopathology and Automated Classification of Pediatric Sarcomas

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

SOHO 2025

ESMO Congress 2025

ACG 2025 Annual Scientific Meeting

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management